Conference Recap
Conference Recap
Multiple Sclerosis Highlights From ECTRIMS-ACTRIMS 2023
Highlights in multiple sclerosis from 2023 ECTRIMS-ACTRIMS include an alternative method of drug...
Conference Recap
Highlights in Multiple Sclerosis From AAN 2023
Conversion to multiple sclerosis and a novel drug to prevent it as well as data regarding continuation of therapy during assisted reproduction are...
Conference Recap
Clinical Advances in Myasthenia Gravis From AAN 2023
Encouraging data for three novel therapies and the association between fatigue and disease severity are among the clinical advances from AAN 2023...
Conference Recap
Therapeutic Highlights From ACTRIMS 2023
From ACTRIMS 2023, Dr Jennifer Graves reports on treatment options for patients with multiple sclerosis, including CSF biomarkers to assess DMT...
Conference Recap
Disease-Modifying Therapies in Progressive Multiple Sclerosis
Key presentations at CMSC 2022 included use of BTK inhibitors in MS, results from the DISCOMS trial, and immune response of MS patients vaccinated...
Conference Recap
Highlights in Relapsing-Remitting Multiple Sclerosis From AAN 2022
Updates in relapsing-remitting multiple sclerosis from 2022 AAN include abstracts on Mediterranean diet, ublituximab, BTK inhibitors,...
Conference Recap
ACTRIMS 2022: Updates in Multiple Sclerosis Symptom Management
Dr Enrique Alvarez reports on ACTRIMS 2022 highlights including an analysis of nabiximols...
Conference Recap
Updates in DMTs and MS Economic Burden From ACTRIMS 2022
Dr Michael Wilson reviews updates from ACTRIMS 2022 on DMTs, autologous stem cell transplant, long-term tolebrutinib results as evident on MRI,...
Conference Recap
Highlights on DMT Use in Progressive MS From CMSC 2021
New data on DMT use in progressive MS presented at CMSC 2021 — including results from the ACAPELLA and EXPAND trials, and the novel agent ATA188...
Conference Recap
Update on Multiple Sclerosis Comorbidities From CMSC 2021
Key updates from CMSC 2021 on prevalent multiple sclerosis comorbidities including prevalence of hypertension, elevated BMI, depression, and...